GlassScriptPhysician profile
Mathew J Putzi
NPI 1538328935
$1,080.94
in general payments reported to CMS, 2019-2025
21 companies · $73.83 in 2025
The $73.83 reported for 2025 was more than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $181 · 2021: $316 · 2022: $217 · 2023: $80.69 · 2024: $42.63 · 2025: $73.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.36 | 2019-2024 | |
| Janssen Biotech, INC. | $131.19 | 2019-2025 | Akeega, Balversa |
| Astellas Pharma US INC | $73.77 | 2019-2020 | |
| Blue Earth Diagnostics | $68.56 | 2021 | |
| Dendreon Pharmaceuticals LLC | $68.10 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $67.77 | 2020-2023 | Myrisk |
| Myovant Sciences INC. | $57.59 | 2021-2022 | |
| Teleflex LLC | $46.48 | 2022-2025 | Urolift, Barrigel |
| Alexion Pharmaceuticals, INC. | $40.16 | 2021-2022 | |
| Foundation Medicine, INC. | $38.45 | 2023 | Foundationone Cdx |
| Endo Pharmaceuticals INC. | $37.04 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.09 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $22.91 | 2021 | |
| 180 Medical, INC. | $22.02 | 2019 | |
| Clarus Therapeutics INC. | $21.45 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $17.97 | 2019 | |
| Endo USA, INC. | $17.63 | 2025 | Aveed, Xiaflex |
| Progenics Pharmaceuticals, INC. | $15.70 | 2022 | |
| Coloplast Corp | $14.40 | 2021 | |
| Urovant Sciences INC | $13.10 | 2022 | |
| Neotract INC. | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Putzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.